Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Outset Medical Inc (NQ: OM )

0.9043 +0.0667 (+7.96%)
Streaming Delayed Price Updated: 4:00 PM EST, Nov 25, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Outset Medical Inc

< Previous 1 2
...
5 6 7 8 9 10 11 12 Next >
Bone Health Technologies Raises $2.5M In New Funding Round, Adds 3 Members To Board
Bone Health Technologies, a MedTech company focused on treating osteoporosis, announced the completion of a new funding round and the appointment of new board members. Funding... 
Via Benzinga
Week Ahead In Biotech (May 2-8): ChemoCentryx Adcom, Ophthalmology Conference Presentations, Earnings Deluge
Biopharma stocks experienced volatility in the week ended April 30, as stocks reacted to earnings, data readouts and a handful of FDA decisions. Earnings prints from big name... 
Via Benzinga
Exposures Product Safety
Outset Medical to Present at BofA Securities 2021 Virtual Health Care Conference
From Outset Medical, Inc.
Via Business Wire
Outset Medical to Report First Quarter 2021 Financial Results on Wednesday, May 5, 2021
From Outset Medical, Inc.
Via Business Wire
Outset Medical Announces Closing of Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares
From Outset Medical, Inc.
Via Business Wire
Outset Medical Prices Equity Offering At $53.50 Per Share
Outset Medical Inc (NASDAQ: OM) has priced an underwritten public offering of 2.5 million common shares sold by the company and some 3.4 million shares sold... 
Via Benzinga
Outset Medical Named a Winner in Round 2 of the KidneyX COVID-19 Kidney Care Challenge
From Outset Medical, Inc.
Via Business Wire
Outset Medical Announces Pricing of Primary and Upsized Secondary Public Offering
From Outset Medical, Inc.
Via Business Wire
The Daily Biotech Pulse: FibroGen Fudges Safety Data, Novartis Strikes Cancer Drug Collaboration, Immutep Gains On Patent Award
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs April 6) AngioDynamics, Inc. (NASDAQ... 
Via Benzinga
Topics Intellectual Property
Exposures Intellectual Property
6 Stocks Moving In Tuesday's After-Hours Session
Gainers 9 Meters Biopharma (NASDAQ: NMTR) shares are trading higher after Form 4 filings from company executives showed the CEO bought 100,000 shares and CFO bought 50,000... 
Via Benzinga
Outset Medical Announces Primary and Secondary Offering of Common Stock
From Outset Medical, Inc.
Via Business Wire
< Previous 1 2
...
5 6 7 8 9 10 11 12 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.